ENTITY
WuXi PharmaTech Cayman

WuXi PharmaTech Cayman (WX US)

32
Analysis
Health CareChina
WuXi PharmaTech (Cayman), Inc. provides research services. The Company offers services include researching, analysis, development, and manufacturing of pharmaceutical and biotechnology products.
more
bullishWuxi Biologics
05 Nov 2023 08:25

ECM Weekly (5th Nov 2023)- Midea, WuxiXDC, Cello, Honasa, Qyuns, Ecopro, Lalatech, Mankind, TWE, VNT

Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.

Logo
414 Views
Share
18 Sep 2019 00:02

Tencent's Offer For Bitauto Is A Done Deal

Last Friday, Tencent Holdings (700 HK) and Hammer Capital tabled a preliminary non-binding proposal for Bitauto Holdings Ltd Adr (BITA US) at...

Logo
684 Views
Share
24 Jun 2019 06:29

Last Week in GER Research: Wuxi Biologics Placement, Budweiser APAC IPO, Slack and CIMC Direct

Below is a recap of the key IPO and fundamental research produced by the Global Equity Research team. This week we update on the placement by Wuxi...

Logo
289 Views
Share
bullishWuxi Biologics
01 Jun 2017 09:29

WuXi Biologics IPO Review - An Opportunity to Get Exposure to Biologics in China

WuXi Biologics (2269 HK) is looking to raise US$461-511m through the issuance of primary (88%) and secondary (12%) shares.  Proceeds will be used...

Share
25 Oct 2016 12:40

Key Drivers of Asia's Healthcare Sector

From a demand perspective, Asia’s population is growing as is longevity. On the supply side, Asia’s number of doctors, nurses, hospitals and...

Share
x